Harbour BioMed Takes Stake in Spruce Biosciences
January 19, 2026 | 14:19
The biotechnology firm purchased equity in Spruce Biosciences to strengthen their existing partnership, signalling confidence in the collaboration and potential synergies between the two companies' development programmes.
Mobile Version